A pan-cancer, pan-Canadian Precision OncologyPlatform at the MUHC ($25M)
Dr. Lorenzo Ferri
A pan-cancer, pan-Canadian Precision Oncology
Platform at the MUHC ($25M)
The current trial-and-error approach to chemotherapy drug selection unnecessarily exposes a significant proportion of patients to toxic drugs which don’t work for them. To replace this, Dr. Lorenzo Ferri and his team at the MGH grow a replica of your tumour in the lab and test hundreds of drugs on it to identify the most effective treatment for your specific tumour. His lab team have a five year plan to shorten and perfect the process, gain approval for use as the new standard of care for esophageal and gastric cancers, then to expand to multiple other types of cancer, while serving cancer
centres across Canada.
“You can help us usher in a new era of precision, personalized cancer treatments.”
Dr. Lorenzo Ferri
Director, Division of Thoracic Surgery
Tumor-on-a chip technology, used by Dr. Ferri to idenify the best drugs to combat cancer.
Steve Paulette, a patient of Dr. Ferri, survived Stage-4 esophageal cancer.
More news
Better Access to Clinical Trials Could Save the Lives of Cancer Patients
After coughing up blood one day, Armen, a security guard at the Montreal General Hospital (MGH-MUHC), was diagnosed with stage 3 lung cancer.
The Making of Together Against Cancer
Here are some of the people who give their best in the fight against cancer.
Together Against Cancer: Campaign Announcement
The Cedars Cancer Foundation and the Montreal General Hospital Foundation are joining forces to fight cancer and launch a major fundraising campaign, with a goal of $100 million.